or Try an Advanced Search...

    Technical Analysis for ENTX - Entera Bio Ltd.

    Grade Last Price % Change Price Change
    D 1.80 -0.55% -0.01
    ENTX closed down 0.55 percent on Friday, November 1, 2024, on 68 percent of normal volume. It ran into resistance at its 50 day moving average.
    Earnings due: Nov 12
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical ENTX trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    50 DMA Resistance Bearish 0.00%
    MACD Bearish Centerline Cross Bearish 0.00%
    MACD Bearish Signal Line Cross Bearish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Outside Day Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Fell Below 20 DMA Bearish -0.55%
    Fell Below 50 DMA Bearish -0.55%
    Older End-of-Day Signals for ENTX ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 19 hours ago
    Rose Above 20 DMA about 21 hours ago
    Rose Above Previous Day's High about 21 hours ago
    Rose Above 50 DMA about 21 hours ago
    Rose Above 10 DMA about 21 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ENTX Chart by TradingView
    Basic chart:

    Profile

    Entera Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in orphan indications and other areas with significant unmet medical need. The Company is initially applying its technology to develop an oral formulation of parathyroid hormone (PTH) for hypoparathyroidism (EB612) and osteoporosis (EB613).
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Endocrine System Hormones Thyroid Osteoporosis Molecule Therapeutics Glands Hypoparathyroidism Parathyroid Hormone

    Is ENTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 4 Are Medical Stocks Lagging Argenx (ARGX) This Year?
    Sep 26 ENTX & OPK Stock May Gain Following Positive PK/PD Research Data
    Sep 25 Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders
    Sep 18 Is Entera Bio (ENTX) Stock Outpacing Its Medical Peers This Year?
    Aug 30 We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate
    Aug 20 Entera Bio to Participate in Upcoming Investor and Scientific Conferences
    Aug 15 All You Need to Know About Entera Bio (ENTX) Rating Upgrade to Buy
    Aug 9 Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates
    Aug 1 Entera’s EB613, the First Once Daily PTH(1-34) Tablet Treatment Dedicated to Post-Menopausal Women with High Risk Osteoporosis Abstract Selected for Presentation at the ASBMR 2024 Annual Meeting - Key SABRE Update Also Expected
    Jul 8 3 Meme Stocks That Can Surge by 200% Before 2025
    See more ENTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.35
    52 Week Low 0.52
    Average Volume 29,030
    200-Day Moving Average 1.76
    50-Day Moving Average 1.85
    20-Day Moving Average 1.82
    10-Day Moving Average 1.85
    Average True Range 0.11
    RSI (14) 45.36
    ADX 10.8
    +DI 13.98
    -DI 13.36
    Chandelier Exit (Long, 3 ATRs) 1.63
    Chandelier Exit (Short, 3 ATRs) 2.04
    Upper Bollinger Bands 1.90
    Lower Bollinger Band 1.75
    Percent B (%b) 0.34
    BandWidth 8.48
    MACD Line 0.00
    MACD Signal Line 0.00
    MACD Histogram -0.0019
    Fundamentals Value
    Market Cap 63.86 Million
    Num Shares 35.5 Million
    EPS -0.34
    Price-to-Earnings (P/E) Ratio -5.29
    Price-to-Sales 2280.62
    Price-to-Book 5.12
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.92
    Resistance 3 (R3) 1.93 1.91 1.90
    Resistance 2 (R2) 1.91 1.88 1.90 1.89
    Resistance 1 (R1) 1.85 1.86 1.84 1.84 1.89
    Pivot Point 1.83 1.83 1.82 1.82 1.83
    Support 1 (S1) 1.77 1.80 1.76 1.76 1.71
    Support 2 (S2) 1.75 1.78 1.74 1.71
    Support 3 (S3) 1.69 1.75 1.70
    Support 4 (S4) 1.68